|
Volumn 19, Issue 8, 2001, Pages 288-292
|
Industrial-scale, genomics-based drug design and discovery
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASES;
GENES;
RNA;
THERAPUTIC TARGETS;
DRUG PRODUCTS;
COMPLEMENTARY DNA;
DOPAMINE RECEPTOR;
LIGAND;
MESSENGER RNA;
PROTEOME;
BIOTECHNOLOGY;
DRUG BINDING SITE;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG SCREENING;
GENE EXPRESSION;
GENE EXPRESSION PROFILING;
GENE MAPPING;
GENE SEQUENCE;
GENOME;
HUMAN;
HYBRIDIZATION;
MASS SPECTROMETRY;
MOLECULAR WEIGHT;
NONHUMAN;
NUCLEIC ACID ANALYSIS;
PHARMACOGENETICS;
PHARMACOPHORE;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
PROTEIN STRUCTURE;
PROTEIN TARGETING;
REVIEW;
RNA SPLICING;
SINGLE NUCLEOTIDE POLYMORPHISM;
TARGET CELL;
DRUG DESIGN;
GENE EXPRESSION;
GENOME;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PHARMACOGENETICS;
PROTEINS;
PROTEOME;
RNA, MESSENGER;
|
EID: 0035426577
PISSN: 01677799
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-7799(01)01696-1 Document Type: Review |
Times cited : (51)
|
References (14)
|